for the Digiday Programmatic Marketing Summit, May 6-8 in Palm Springs.
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
OpenAI turns on cost-per-click ads inside ChatGPT
The move come as the platform looks to hire its first Advertising Marketing Science Lead.
Digiday+ Research: Marketing workflows benefit from AI, but trust is still a barrier to adoption
Research shows that while marketers see AI’s benefits, trust and complexity issues are barriers to widespread adoption.
David’s Bridal invests in its creator strategy as part of its post-bankruptcy comeback
David’s Bridal is investing more heavily in creators as part of a broader push to modernize the business.